Telomerase activity and telomerase reverse transcriptase expression induced by selenium in rat hepatocytes

Biomedical and Environmental Sciences

Volumn 22, Issue 4, 2009, Pages 311-317

  Yu, Ri An ^a   Chen, Hua Jie ^b   He, Ling Fei ^a   Chen, Bing ^a   Chen, Xue Min ^b  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C myc; P53; Selenium; Telomerase; Telomerase reverse transcriptase

Indexed keywords

RATTUS;

EID: 70449091952     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(09)60061-1     Document Type: Article

References (32)

1. Liu Y, Bohr V A, Lansdorp P (2008). Telomere, telomerase, and aging. Mech Ageing Dev 129(1-2), 1-2.
2. Olivieri O, Stanzial A M, Girelli D, et al. (1994). Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. Am J Clin Nutr 60(4), 510- 517.
3. Liu Q, Wang H, Hu D, et al. (2004). Effects of trace elements on the telomere lengths of hepatocytes L-02 and hepatoma cells SMMC-7721. Biol Trace Elem Res 100(3), 215-227.
4. Houben J M, Moonen H J, van Schooten F J, et al. (2008). Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 44(3), 235-246.
5. Liu Q, Wang H, Hu D C, et al. (2003). Effects of sodium selenite on telomerase activity and telomere length. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35(12), 1117-1122.
6. Cui Q H, Tang C C, Huang Y G (2002). Effects of lead and selenium on telomere binding protein Raplp, telomerase and telomeric DNA in Saccharomyces cerevisiae. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(2), 240-244.
7. Hornsby P J (2007).Telomerase and the aging process. Exp Gerontol 42(7), 575-581.
8. Ostler E L, Wallis C V, Aboalchamat B, et al. (2000). Telomerase and the cellular lifespan: implications of the aging process. J Pediatr Endocrinol Metab 13(Suppl 6), 1467-1476.
9. Shawi M, Autexier C. (2008). Telomerase, senescence and ageing. Mech Ageing Dev 129(1-2), 3-10.
10. Dong X X, Hui Z J, Xiang W X, et al. (2007). Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. J Cardiovasc Pharmacol 49(2), 111-115.
11. Imanishi T, Kobayashi K, Kuki S, et al. (2006). Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation. Atherosclerosis 189(2), 288-296.
12. Chen H J, Yu R A, He L F, et al. (2007). Inhibitory effects of selenium on telomerase activity and hTERT expression in cadmium-transformed 16HBE cells. Biomed Environ Sci 20(4), 307-312.
13. Zhang J X, Zhang Z K, Sheng H P, et al. (2000). Telomerase activity is not related to apoptosis in leukemic cell lines. Life Sci 66(18), 1713-1723.
14. Xiang H, Wang J, Mao Y W, et al. (2000). hTERT can function with rabbit telomerase RNA: regulation of gene expression and attenuation of apoptosis. Biochem Biophys Res Commun 278(3), 503-510.
15. Bermudez Y, Erasso D, Johnson N C, et al. (2006). Telomerase confers resistance to caspase-mediated apoptosis. Clin Interv Aging 1(2), 155- 167.
16. Ren J G, Xia H L, Tian Y M, et al. (2001). Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett 488(3), 133-138.
17. Yu L, Dai Y, Yuan Z, et al. (2007). Effects of rare earth elements on telomerase activity and apoptosis of human peripheral blood mononuclear cells. Biol Trace Elem Res 116(1), 53-59.
18. Wu C H, van Riggelen J, Yetil A, et al. (2007). Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci U S A 104(32), 13028- 13033.
19. Zhuang D, Mannava S, Grachtchouk V, et al. (2008). C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27(52), 6623-6634.
20. Schmid G, Kramer M P, Maurer M, et al. (2007). Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence. J Cell Biochem 101(6), 1355-1369.
21. Wesierska-Gadek J. Ranftler C, Schmid G (2005). Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence. J Physiol Pharmacol 56(Suppl 2), 77-88. (Pubitemid 44933670)
22. Cerni C. (2000). Telomeres, telomerase, and myc. An update. Mutat Res 462(1), 31-47.
23. Wang J, Xie L Y, Allan S, et al. (1998). Myc activates telomerase. Genes Dev 12(12), 1769-1774.
24. Geng Z, Zhang D. Liu Y (2003). Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene. Chin Med J (Engl) 116(10), 1467-1470.
25. Liu Y C, Chen C J, Wu H S, et al. (2004). Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol 30(4), 384-390.
26. Dong Y, Li T, Wang Y, et al. (2004) Expression of human telomerase reverse transcriptase and c-myc transcripts in endometrial carcinoma and its precursors. Zhonghua Bing Li Xue Za Zhi 33(1), 40-43. (In Chinese)
27. Rahman R, Latonen L, Wiman K G (2005). hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncongene 24(8), 1320-1327.
28. Beliveau A, Yaswen P (2007). Soothing the watchman: telomerase reduces the p53-dependent cellular stress response. Cell Cycle 6(11), 1284-1287.
29. Yu R A, Yang C F, Chen X M (2006). DNA damage, apoptosis and C- myc, C-fos, and C-jun overexpression induced by selenium in rat hepatocytes. Biomed Environ Sci 19(3), 197-204.
30. K C S, Cárcamo J M, Golde D W (2006). Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC. Mutat Res 593(1-2), 64-79.
31. Rudolf E, Rudolf K, Cervinka M (2008) Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol Toxicol 24(2), 123-141.
32. Yu R A, Xia T, Wang A G, et al. (2006). Effects of selenium and zinc on renal oxidative stress and apoptosis induced by fluoride in rats. Biomed Environ Sci 19(6), 439-444.